Contrast injection developer E-Z-EM announced the death of Howard Stern, co-founder and chairman emeritus of the company.
Stern co-founded Lake Success, NY-based E-Z-EM in 1962 to develop and market the first unit-dose product to eliminate cross-contamination during the administration of barium sulfate contrast media.
He served as director of E-Z-EM from the firm's founding until his passing, and also served as its chairman of the board from its founding until December 2004, when he was named chairman emeritus. He also served as chief executive officer until 1990, as president and CEO from 1990 to 1994, and again from 1997 to 2000.
Stern was also a director of AngioDynamics, which he co-founded in 1988 as a division of E-Z-EM and served as the chairman of the board from that company's founding until 2004.
He was 74 at the time of his death from brain cancer.
By AuntMinnie.com staff writers
January 4, 2006
Related Reading
E-Z-EM shows new blood analyzer, November 29, 2005
Road to RSNA, E-Z-EM, November 4, 2005
E-Z-EM debuts IRiSCT, October 13, 2005
E-Z-EM notches record revenue in Q1, October 12, 2005
E-Z-EM joins new Nasdaq index, August 10, 2005
Copyright © 2006 AuntMinnie.com
